Sophie R. Vaccarino, MD, MSc

Cumming School of Medicine, University of Calgary, Alberta, Canada

JCP
Cognitive Effects of ECT in Schizophrenia: A Review
Review Article

June 5, 2024

ECT was not associated with any significant cognitive deficits in people with treatment-resistant schizophrenia across global cognition, attention, language, visuospatial function, and executive function domains. The majority of studies...
Sophie R. Vaccarino, Anthony L. Vaccarino
JCP
Systematic Review

January 4, 2022

The cognitive effects of ketamine have not been thoroughly investigated in depressed populations. This systematic review sought to determine the objective neurocognitive effects of ketamine in individuals with unipolar...
Sophie R. Vaccarino, Fathima Adamsahib, Roumen V. Milev, et al
JCP
Original Research

July 21, 2020

What is the efficacy of antidepressants and other agents for treating cognitive impairment in adults with major depressive disorder? Review available research in this CME journal activity.
Michelle J. Blumberg, Sophie R. Vaccarino, Shane J. McInerney
JCP
Review Article

October 8, 2019

Depression can cause notable cognitive deficits. Read this review article to learn about the efficacy of the wakefulness-promoting drug modafinil in the treatment of cognitive impairments associated with major...
Sophie R. Vaccarino, Shane J. McInerney, Sidney H. Kennedy, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe